We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+19.44%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$28.4B
AUM Growth
+$3.28B
(+13%)
Cap. Flow
+$244M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
22.69%
Holding
696
New
203
Increased
144
Reduced
156
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$382M |
| 2 |
JPMorgan Chase
JPM
|
+$330M |
| 3 |
Arista Networks
ANET
|
+$263M |
| 4 |
Zebra Technologies
ZBRA
|
+$217M |
| 5 |
Walt Disney
DIS
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$366M |
| 2 |
Cisco
CSCO
|
+$309M |
| 3 |
United Airlines
UAL
|
+$265M |
| 4 |
Western Digital
WDC
|
+$196M |
| 5 |
Medtronic
MDT
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.35% |
| 2 | Consumer Discretionary | 10.61% |
| 3 | Industrials | 10.56% |
| 4 | Healthcare | 9.33% |
| 5 | Financials | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Solid Biosciences
SLDB
$896M
| $7.99M | 0.03% |
1,640,821
| – | – |
|
377
Vaxcyte
PCVX
$8.76B
| $7.96M | 0.03% |
244,775
+80,135
| +49% | +$2.63M |
|
378
Achieve Life Sciences
ACHV
$688M
| $7.92M | 0.03% |
3,504,333
+3,083,333
| +732% | +$8.78M |
|
379
Olin
OLN
$2.11B
| $7.85M | 0.03% |
+390,779
| New | +$8.12M |
|
380
Eos Energy Enterprises
EOSE
$1.49B
| $7.8M | 0.03% |
+1,523,886
| New | +$7.47M |
|
381
Philip Morris
PM
$291B
| $7.67M | 0.03% |
+42,136
| New | +$7.24M |
|
382
SM Energy
SM
$7.39B
| $7.6M | 0.03% |
307,413
-215,561
| -41% | -$5.22M |
|
383
Krystal Biotech
KRYS
$9.77B
| $7.41M | 0.03% |
+53,934
| New | +$7.92M |
|
384
Cadiz
CDZI
$284M
| $7.41M | 0.03% |
2,478,308
-257,601
| -9% | -$740K |
|
|
TWFG
385
TWFG Inc
TWFG
$376M
| $7.41M | 0.03% |
211,586
-51,738
| -20% | -$1.72M |
|
386
Peloton Interactive
PTON
$2.44B
| $7.35M | 0.03% |
1,059,263
+309,263
| +41% | +$2.01M |
|
387
Cabaletta Bio
CABA
$450M
| $7.3M | 0.03% |
+4,800,000
| New | +$7.49M |
|
388
APi Group
APG
$18.1B
| $7.23M | 0.03% |
212,435
-489,013
| -70% | -$14M |
|
|
ATYR
389
aTyr Pharma
ATYR
$50.2M
| $7.16M | 0.03% |
1,412,749
+134,852
| +11% | +$531K |
|
390
BrightView Holdings
BV
$1.06B
| $7.08M | 0.02% |
+425,000
| New | +$6.36M |
|
391
Sunstone Hotel Investors
SHO
$2.01B
| $7.07M | 0.02% |
814,653
-940,302
| -54% | -$8.11M |
|
392
Celanese
CE
$4.81B
| $6.96M | 0.02% |
+125,854
| New | +$6.27M |
|
|
MRUS
393
DELISTED
Merus
MRUS
| $6.58M | 0.02% |
125,000
+56,818
| +83% | +$2.67M |
|
|
GPGI
394
GPGI Inc
GPGI
$4.22B
| $6.43M | 0.02% |
456,556
+100,000
| +28% | +$1.23M |
|
|
LENZ
395
LENZ Therapeutics
LENZ
$168M
| $6.36M | 0.02% |
217,113
+75,000
| +53% | +$2.04M |
|
396
Ionis Pharmaceuticals
IONS
$9.42B
| $6.28M | 0.02% |
+159,008
| New | +$5.2M |
|
397
Iris Energy
IREN
$14.3B
| $6.1M | 0.02% |
+418,961
| New | +$3.4M |
|
398
Brown-Forman Class B
BF.B
$12.9B
| $6.05M | 0.02% |
+225,000
| New | +$7.22M |
|
399
Larimar Therapeutics
LRMR
$434M
| $6M | 0.02% |
2,075,882
+633,409
| +44% | +$1.47M |
|
400
Janux Therapeutics
JANX
$982M
| $5.98M | 0.02% |
258,678
-150,000
| -37% | -$3.95M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2025 Portfolio in Review
As of Q2 2025, Alyeska Investment Group held 696 positions worth $28.4B, up 13% from $25.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Alyeska Investment Group's Q2 2025 filing shows 203 new, 144 increased, 156 reduced and 154 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,335,726 shares worth $412M. The largest sale was Amazon, an estimated $366M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Alyeska Investment Group's largest Q2 2025 buy was Alphabet (Google) Class A: 2,335,726 shares worth $412M.
- Alyeska Investment Group added most to JPMorgan Chase in Q2 2025, an estimated $330M increase.
- Alyeska Investment Group's biggest Q2 2025 reduction was Amazon, cutting an estimated $366M.
- Alyeska Investment Group fully exited Sherwin-Williams in Q2 2025, selling an estimated $188M.
- Alyeska Investment Group's ten largest holdings make up 23% of its $28.4B portfolio in Q2 2025.
- Alyeska Investment Group opened 203 new positions and closed 154 in Q2 2025.
- Alyeska Investment Group's portfolio value rose 13% quarter-over-quarter to $28.4B.
Based on Alyeska Investment Group's 13F filing for Q2 2025, filed 14 Aug 2025.